+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-09-03Number of Pages: 155

Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Global Mice Model Market: Snapshot 

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

 

mice-model-market

 

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
      1.2.1 Secondary Research
      1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations
 
Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2013
2.2 Market Snapshot: Global Mice Model Market (2014 and 2023E)
2.3 Global Mice Model Market, by Type, 2014 (USD Million)
2.4 Global Mice Model Market, by Application, 2014 (USD Million)
2.5 Global Mice Model Market, by Services, 2014 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
 
Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
      3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
      3.2.1 End-user Analysis of Mice Model Market (Value %), 2013
3.3 Market Dynamics
      3.3.1 Drivers
              3.3.1.1 Growing investment in biomedical research
              3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
              3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
              3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
      3.3.2 Restraints
              3.3.2.1 Rising concern about animal use across the globe would restrain the market
              3.3.2.2 Development of alternative technologies
      3.3.3 Opportunities
              3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
      3.5.1 Mice Model Market Analysis: The U.S. and China
      3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography      
      3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
      3.6.1 Global Market Share Analysis, by Key Players, 2013 (Value %)
      3.6.2 Global Market Share Analysis, by Key Players, 2014 (Value %)
      3.6.3 Heat Map Analysis, by Key Geography, 2014 (Market Share)
      3.6.4 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
 
Chapter 4 Global Mice Model Market, by Type
4.1 Overview
      4.1.1 Global Mice Model Market, by Type, 2013–2014 (USD Million)
      4.1.2 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
4.2 Transgenic Mice Model
      4.2.1 Transgenic Mice Applications in Various Specialties (%)
      4.2.2 Global Transgenic Mice Model Market, 2013–2023E (USD Million)
4.3 Hybrid/Congenic Mice Model
      4.3.1 Global Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
4.4 Knockout Mice Model
      4.4.1 Knockout Mice Applications in Various Specialties, 2014 (%)
      4.4.2 Global Knockout Mice Model Market, 2013–2023E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
      4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
4.6 Outbred Mice Model
      4.6.1 Global Outbred Mice Model Market, 2013–2023E (USD Million)
4.7 Inbred Mice Model
              4.7.1.1 Inbred Mice Applications in various Specialties (%), 2014
              4.7.1.2 Global Inbred Mice Model Market, 2013–2023E (USD Million)
4.8 Transplantation Mice Model
      4.8.1 Global Transplantation Mice Model Market, 2013–2023E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
      4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
 
Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
      5.1.1 Global Mice Model Market, by Application, 2013–2014 (USD Million)
      5.1.2 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
5.2 Immunology
      5.2.1 Global Immunology Mice Model Market, 2013–2023E (USD Million)
      5.2.2 Number of Immunology Mice Models, by Major Companies
      5.2.3 Immunology Mice Model Market Share, by Model Type, 2014
5.3 Central Nervous System (CNS)
      5.3.1 Global CNS Mice Model Market, 2013–2023E (USD Million)
      5.3.2 Number of CNS Mice Models, by Major Companies
      5.3.3 CNS Mice Model Market Share, by Model Type, 2014
5.4 Oncology
      5.4.1 Global Oncology Mice Model Market, 2013–2023E (USD Million)
      5.4.2 Number of Oncology Mice Models, by Major Companies
      5.4.3 Oncology Mice Model Market Share, by Model Type, 2014
5.5 Cardiovascular
      5.5.1 Global Cardiovascular Mice Model Market, 2013–2023E (USD Million)
      5.5.2 Number of Cardiovascular Mice Models, by Major Companies
      5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2014
5.6 Diabetes
      5.6.1 Global Diabetes Mice Model Market, 2013–2023E (USD Million)
      5.6.2 Number of Diabetes Mice Models, by Major Companies
      5.6.3 Diabetes Mice Model Market Share, by Model Type, 2014
5.7 Metabolism & Regulation
      5.7.1 Global Metabolism & Regulation Mice Model Market, 2013–2023E (USD Million)
      5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
 
Chapter 6 Global Mice Model Market, by Services
6.1 Overview
      6.1.1 Global Mice Model Market, by Services, 2013–2014 (USD Million)
      6.1.2 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
6.2 Breeding and Rederivation Services
      6.2.1 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
      6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
6.4 Quarantine Services
      6.4.1 Global Quarantine Services Market, 2013–2023E (USD Million)
6.5 Genetic Testing Services
      6.5.1 Global Genetic Testing Services Market, 2013–2023E (USD Million)
6.6 Model In-licensing Services
      6.6.1 Global Model In-licensing Market, 2013–2023E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
      6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
6.8 Genetically Engineered Model Services
      6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
      6.9.1 Global Other Services Market, 2013–2023E (USD Million)
 
Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
      7.1.1 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
      7.1.2 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
      7.1.3 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
7.2 North America
      7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2013
      7.2.2 North America Mice Model Market Revenue, 2013–2023E (USD Million
      7.2.3 U.S.
              7.2.3.1 U.S. Mice Model Market, 2013–2023E (USD Million)
      7.2.4 Canada
              7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
              7.2.4.2 Canada Mice Model Market, 2013–2023E (USD Million)
7.3 Europe
      7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2013
      7.3.2 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.3 Germany
              7.3.3.1 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.4 U.K.
              7.3.4.1 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.5 Rest of Europe
              7.3.5.1 Rest of Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.4 Asia Pacific
      7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
      7.4.2 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
      7.4.3 Japan
              7.4.3.1 Japan Mice Model Market, 2013–2023E (USD Million)
      7.4.4 China
              7.4.4.1 China Mice Model Market, 2013–2023E (USD Million)
      7.4.5 Rest of Asia Pacific
              7.4.5.1 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
7.5 Latin America
      7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2013
      7.5.2 Latin America Mice Model Market, 2013–2023E (USD Million)
      7.5.3 Brazil
              7.5.3.1 Brazil Mice Model Market, 2013–2023E (USD Million)
      7.5.4 Mexico
              7.5.4.1 Mexico Mice Model Market, 2013–2023E (USD Million)
      7.5.5 Rest of Latin America
              7.5.5.1 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
7.6 Middle East & North Africa (MENA)
      7.6.1 MENA Mice Model Market, 2013–2023E (USD Million)
      7.6.2 Saudi Arabia (KSA)
              7.6.2.1 Saudi Arabia Mice Model Market, 2013–2023E (USD Million)
      7.6.3 UAE
              7.6.3.1 UAE Mice Model Market, 2013–2023E (USD Million)
      7.6.4 Israel
              7.6.4.1 Israel Mice Model Market, 2013–2023E (USD Million)
      7.6.5 Rest of MENA
              7.6.5.1 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
7.7 Rest of the World (RoW)
      7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2013
      7.7.2 Rest of World Mice Model Market, 2013–2023E (USD Million)
 
Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil
 
Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Deltagen, Inc.
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 genOway S.A.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Harbour Antibodies BV
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 ImmunoGenes AG
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 SAGE Labs
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 The Jackson Laboratory
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 TransGenic, Inc.
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments

List of Figures
 
FIG. 1 Global Mice Model Market Segmentation
FIG. 2 Global Mice Model Market, By Type, 2014 (USD Million)
FIG. 3 Global Mice Model Market, By Application, 2014 (USD Million)
FIG. 4 Global Mice Model Market, By Services, 2014 (USD Million)
FIG. 5 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
FIG. 6 Biomedical Research Growth Rate, 2007–2012, (%)
FIG. 7 Mice Model Market Analysis: The U.S. and China, 2014
FIG. 8 Market Attractiveness Analysis: Global Mice Model Market, by Geography
FIG. 9 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
FIG. 10 Market Share Analysis: Global Mice Model Market, 2013 (Value %)
FIG. 11 Market Share Analysis: Global Mice Model Market, 2014 (Value %)
FIG. 12 Heat Map Analysis, by Key Geography, 2014 (Market Share)
FIG. 13 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
FIG. 14 Transgenic Mice Applications in Various Specialties (%), 2014
FIG. 15 Transgenic Mice Model Market, 2013–2023E (USD Million)
FIG. 16 Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
FIG. 17 Knockout Mice Applications in Various Specialties, 2014 (%)
FIG. 18 Knockout Mice Model Market, 2013–2023E (USD Million)
FIG. 19 Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
FIG. 20 Outbred Mice Model Market, 2013–2023E (USD Million)
FIG. 21 Inbred Mice Applications in various Specialties (%), 2014
FIG. 22 Inbred Mice Model Market, 2013–2023E (USD Million)
FIG. 23 Transplantation Mice Model Market, 2013–2023E (USD Million)
FIG. 24 Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
FIG. 25 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 26 Immunology Mice Models, by Major Companies
FIG. 27 Immunology Mice Model Market Share, by Model Type, 2014
FIG. 28 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 29 Number of CNS Mice Models, by Major Companies
FIG. 30 Mice Model Market Share, by Model Type, 2014
FIG. 31 Oncology Mice Models Market, 2013–2023E (USD Million)
FIG. 32 Number of CNS Mice Models, by Major Companies
FIG. 33 Oncology Mice Model Market Share, by Model Type, 2014
FIG. 34 Cardiovascular Mice Models Market, 2013–2023E (USD Million)
FIG. 35 Number of CNS Mice Models, by Major Companies
FIG. 36 Cardiovascular Mice Model Market Share, by Model Type, 2014
FIG. 37 Diabetes Mice Models Market, 2013–2023E (USD Million)
FIG. 38 Number of Diabetes Mice Models, by Major Companies
FIG. 39 Diabetes Mice Model Market Share, by Model Type, 2014
FIG. 40 Metabolism & Regulation Mice Models Market, 2013–2023E (USD Million)
FIG. 41 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
FIG. 42 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
FIG. 43 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
FIG. 44 Global Quarantine Services Market, 2013–2023E (USD Million)
FIG. 45 Global Genetic Testing Services Market, 2013–2023E (USD Million)
FIG. 46 Global Model In-licensing Market, 2013–2023E (USD Million)
FIG. 47 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
FIG. 48 Genetically Engineered Model Services
FIG. 49 Global Other Services Market, 2013–2023E (USD Million)
FIG. 50 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
FIG. 51 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
FIG. 52 U.S. Mice Model Market, 2013–2023E (USD Million)
FIG. 53 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
FIG. 54 Canada Mice Model Market, 2013–2023E (USD Million)
FIG. 55 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 56 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 57 Rest of Europe Market Revenue, 2013–2023E (USD Million)
FIG. 58 Japan Mice Model Market, 2013–2023E (USD Million)
FIG. 59 China Mice Model Market, 2013–2023E (USD Million)
FIG. 60 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
FIG. 61 Brazil Mice Model Market, 2013–2023E (USD Million)
FIG. 62 Mexico Mice Model Market, 2013–2023E (USD Million)
FIG. 63 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
FIG. 64 Saudi Arabia Mice Model Market, 2013 – 2023E (USD Million)
FIG. 65 UAE Mice Model Market, 2013–2023E (USD Million)
FIG. 66 Israel Mice Model Market, 2013–2023E (USD Million)
FIG. 67 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
FIG. 68 Rest of World Mice Model Market, 2013–2023E (USD Million)
FIG. 69 Charles River Laboratories International, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 70 Charles River Laboratories International, Inc.: Business Segments
FIG. 71 Charles River Laboratories International, Inc.: Financials, 2012–2014
FIG. 72 Deltagen, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 73 Deltagen, Inc.: Financials, 2012–2014 (USD Million)
FIG. 74 genOway S.A.: Annual Revenue, 2012–2014 (USD Million)
FIG. 75 genOway S.A.: Financials, 2012–2014 (USD Million)
FIG. 76 The Jackson Laboratory: Annual Revenue, 2012–2014 (USD million)
FIG. 77 The Jackson Laboratory: Financials, 2012–2014 (USD million)
FIG. 78 TransGenic, Inc.: Annual Revenue, 2012–2014 (USD million)
FIG. 79 TransGenic, Inc.: Financials, 2012–2014 (USD million)

List of Tables
 
TABLE 1 Global Mice Consumption, 2013
TABLE 2 Market Snapshot: Global Mice Model Market (2014 and 2023E )
TABLE 3 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
TABLE 4 End-user Analysis of Mice Model Market (Value %), 2013
TABLE 5 Global Mice Model Market, by Type, 2013–2014 (USD Million)
TABLE 6 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
TABLE 7 Global Mice Model Market, by Application, 2013–2014 (USD Million)
TABLE 8 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
TABLE 9 Global Mice Model Market, by Services, 2013–2014 (USD Million)
TABLE 10 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
TABLE 11 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
TABLE 12 North America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 13 Europe Population, GDP, and Health care Expenditure, 2011–2013
TABLE 14 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 15 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
TABLE 16 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 17 Latin America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 18 Latin America Mice Model Market, 2013–2023E (USD Million)
TABLE 19 MENA Mice Model Market, 2013–2023E (USD Million)
TABLE 20 Row Population, GDP, and Health care Expenditure, 2011–2013

 
Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is likely to be further widened by the introduction of new models such as immunedeficient and humanizing mouse in which human tissues and cells or genes are reconstituted. With 99% of their genes shared with humans, new possibilities were opened for genetic testing. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in the identification of potentially conforming homologous mutations and disease genes.
 
This report studies the global mice model market from five perspectives: by type of model, application, services, and geography. Based on type of model, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Based on application, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services and other services such as surgical and line rescue. Geographically, the market has been studied and estimated for six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. 
 
The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. The market overview section includes market attractiveness analysis by geography coupled with qualitative analysis on regulatory scenarios, and impact analysis of key industry events to provide a thorough analysis of the overall competitive scenario in the global mice model market. The market overview section of the report also includes the qualitative and quantitative analysis of the competitive landscape. 
 
Market share analysis is also provided in the market overview section of the report for 2014 in terms of value (%). The report also provides important recommendations for market players and new entrants. These recommendations would enable existing market players to expand their market share and help new companies establish their presence in the mice model market across the globe. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments. Key players mentioned in the report include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, Taconic Biosciences, Inc., and TransGenic, Inc.  
The global mice model market is segmented into the following categories: 
 
Global Mice Model Market, by Type
  • Transgenic Mice Model
  • Hybrid/Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen-induced and Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned/Surgically Modified Mice Model
Global Mice Model Market, by Specialty 
  • Immunology
  • Central Nervous System (CNS)
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation
Global Mice Model Market, by Services 
  • Breeding and Rederivation Services
  • Cryopreservation and Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In vivo and In vitro Pharmacology Services
  • Genetically Engineered Model Services
  • Other Services (Surgical and Line Rescue)
Global Mice Model Market, by Geography 
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & North Africa (MENA)
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MENA
  • Rest of the World (RoW)


 
 
Back To Top